Preventive Effects of Epigallocatechin-3-O-Gallate Against Replicative Senescence Associated With P53 Acetylation in Human Dermal Fibroblasts

Oxidative Medicine and Cellular Longevity - United States
doi 10.1155/2012/850684
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

ING2 Regulates the Onset of Replicative Senescence by Induction of P300-Dependent P53 Acetylation

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2005English

Cardioprotective Effect of Epigallocatechin-3-Gallate Against Myocardial Infarction in Hypercholesterolemic Rats

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2014English

P53 Isoforms Regulate Aging- And Tumor-Associated Replicative Senescence in T Lymphocytes

Journal of Clinical Investigation
Medicine
2013English

Knockdown of CDK2AP1 in Primary Human Fibroblasts Induces P53 Dependent Senescence

PLoS ONE
Multidisciplinary
2015English

Cancer Therapeutics With Epigallocatechin-3-Gallate Encapsulated in Biopolymeric Nanoparticles

International Journal of Pharmaceutics
Pharmaceutical Science
2017English

Beneficial Storage Effects of Epigallocatechin-3-O-Gallate on the Articular Cartilage of Rabbit Osteochondral Allografts

Cell Transplantation
TransplantationBiomedical EngineeringCell Biology
2009English

Role of P53 and NF-κB in Epigallocatechin-3-Gallate-Induced Apoptosis of LNCaP Cells

Oncogene
Cancer ResearchGeneticsMolecular Biology
2003English

Regulation of Collagenase Expression During Replicative Senescence in Human Fibroblasts by Akt-Forkhead Signaling

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2001English

Differentiation-Associated Alteration in Sensitivity to Apoptosis Induced by (-)-Epigallocatechin-3-O-Gallate in HL-60 Cells

Biomedical Research
BiochemistryMedicineGeneticsMolecular Biology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy